Search

Resistance training (RT) is a fundamental component of exercise prescription aimed at improving overall health and function. RT techniques such as cluster set (CS) configurations, characterized by additional short intra-set or inter-repetition rest intervals, have been shown to maintain acute muscular force, velocity, and ‘power’ outputs across a RT session, and facilitate positive longer-term neuromuscular adaptations. However, to date CS have mainly been explored from a human performance perspective despite potential for application in health and clinical exercise settings. Therefore, this current opinion piece aims to highlight emerging evidence and provide a rationale for why CS may be an advantageous RT technique for older adults, and across several neurological, neuromuscular, cardiovascular and pulmonary settings. Specifically, CS may minimize acute fatigue and adverse physiologic responses, improve patient tolerance of RT and promote functional adaptations (i.e., force, velocity, and power). Moreover, we propose that CS may be a particularly useful exercise rehabilitation technique where injury or illness, persistent fatigue, weakness and dysfunction exist. We further suggest that CS offer an alternative RT strategy that can be easily implemented alongside existing exercise/rehabilitation programs requiring no extra cost, minimal upskilling and/or time commitment for the patient and professional. In light of the emerging evidence and likely efficacy in clinical exercise practice, future research should move toward further direct investigation of CS-based RT in a variety of adverse health conditions and across the lifespan given the already demonstrated benefits in healthy populations.

This study investigated the stability of three repetition maximum (3RM) strength during the deadlift. Eleven participants performed four testing sessions comprising a one repetition maximum test and 3RM tests separated by 48 h. Preparedness was assessed before each testing session using countermovement jumps and by measuring barbell velocity during each set of deadlifts. Trivial statistically significant differences were determined for the 3RM between T1 and both T2 ( p = 0.012; ES [95% CI] = −0.1 [−0.58, 0.41]) and T3 ( p = 0.027; ES [95% CI] = −0.09 [−0.57, −0.43]). No significant differences were noted between T2 and T3 ( p = 0.595; ES [95% CI] = 0.01 [−0.49, 0.50]). No significant differences in jump height ( p = 0.071), time-to-take-off ( p = 0.862), eccentric displacement ( p = 0.209), or mean force during any countermovement jump sub-phase were found between each session ( p = 0.529–0.913). Small differences in barbell mean velocity were found between both T1–T2 (effect size statistics (ES) = −0.21–0.27) and T2–T3 (ES = 0.31–0.48), while trivial differences were found at others. Therefore, 3RM deadlift strength appears stable enough over a microcycle to continue using traditionally recommended heavy/light programming strategies.

The primary aim of this study was to investigate the stability of the six-repetition maximum (6RM) deadlift over the length of a five-day microcycle and whether the fatigue induced by maximal effort testing detrimentally impacted preparedness. Twelve participants performed four testing sessions, comprising a one-repetition maximum test and three 6RM tests separated by 48 hours. Countermovement jumps were performed before each testing session, and barbell velocity was measured during each warm-up set to assess changes in preparedness. The 6RM deadlift was not statistically different between any of the testing sessions ( p = .056; ηp2 = 0.251). Similarly, there were no significant differences in jump height or other CMJ variables between sessions ( p > .05). There were small to moderate differences in mean barbell velocity between the first and second 6RM test ( g = 0.24–0.88), while there were only small differences in mean velocity (MV) between the second and third 6RM test at some of the warm-up loads (40% 6RM: g = 0.20; 80% 6RM: g = −0.47). Taken collectively, these data indicate that 6RM deadlift strength is stable over five days and does not appear to induce sufficient fatigue to impact vertical jump performance or rating of perceived exertion despite some changes in barbell velocity.

Force plates are commonly used when assessing vertical jumping performance but are not always affordable or practical tools for all testing situations. Twenty-four participants volunteered to take part in a study investigating the agreement between bilateral force plates and a new commercially available contact mat that records jump height, flight-time (FT), and FT of individual limbs during both countermovement (CMJ) and squat (SJ) jumps. Each participant performed six jumps of each type while standing on a contact mat placed upon a pair of in-ground force plates. When compared to the force plate via ordinary least products regression, the contact mat agreed with force plate CMJ and SJ jump height, individual limb FT during CMJs, and left-leg FT during SJs. The bilateral contact mat provided valid assessment of individual limb FT during CMJs, but not SJs. Practitioners can therefore use a bilateral contact mat interchangeably with bilateral force plates to measure SJ and CMJ performance.

Background: Symptom burden remains a critical concern for individuals with non-small cell lung cancer (NSCLC) following the completion of treatment. The most common symptom clusters, dyspnea (shortness of breath) and fatigue,can contribute to physical decline, reductions in quality of life, and a higher risk of comorbidities and mortality. Dyspnea is a primary limiter of exercise capacity in individuals with lung cancer, resulting in exercise avoidance and an accelerated physical decline. As such, designing resistance training with cluster sets to mitigate symptoms of dyspnea and fatigue may result in improved exercise tolerance. Thus, maintainingthe exercise stimulus via cluster sets, combined with improved tolerance of the exercise, could result in maintenance of physical function and quality of life. The purpose of this study is to investigate the feasibility and preliminary efficacy of a hybrid-delivery home-based cluster-set resistance training program in individuals with NSCLC. Methods: Individuals with NSCLC (n=15), within 12-months of completion of treatment will be recruited to participate in this single arm feasibility trial. Participants will complete 8-weeks of home-based resistance training designed to minimizedyspnea and fatigue. The hybrid-delivery of the program will include supervised sessions in the participants’ home, and virtual supervision via video conferencing. The primary outcome of feasibility will be quantifiedby recruitment rates, retention, acceptability, and intervention fidelity. Exploratory outcomes (dyspnea, fatigue, quality of life, physical function, and body composition) will be assessed pre- and post- intervention. Discussion: This study will provide important data on the feasibility of delivering this intervention and inform procedures for a future randomized controlled trial. Trial Registration: Record not yet public

Background If interplanetary travel is to be successful over the coming decades, it is essential that countermeasures to minimize deterioration of the musculoskeletal system are as effective as possible, given the increased duration of spaceflight associated with such missions. The aim of this review, therefore, is to determine the magnitude of deconditioning of the musculoskeletal system during prolonged spaceflight and recommend possible methods to enhance the existing countermeasures. Methods A literature search was conducted using PubMed, Ovid and Scopus databases. 5541 studies were identified prior to the removal of duplicates and the application of the following inclusion criteria: (1) group means and standard deviations for pre- and post-spaceflight for measures of strength, muscle mass or bone density were reported (or provided by the corresponding author when requested via e-mail), (2) exercise-based countermeasures were included, (3) the population of the studies were human, (4) muscle function was assessed and (5) spaceflight rather than simulated spaceflight was used. The methodological quality of the included studies was evaluated using a modified Physiotherapy Evidence Database (PEDro) scale for quality, with publication bias assessed using a failsafe N (Rosenthal method), and consistency of studies analysed using I2 as a test of heterogeneity. Secondary analysis of studies included Hedges’ g effect sizes, and between-study differences were estimated using a random-effects model. Results A total of 11 studies were included in the meta-analyses. Heterogeneity of the completed meta-analyses was conducted revealing homogeneity for bone mineral density (BMD) and spinal muscle size (Tau2 I2 = 0.00%, p > 0.05), although a high level of heterogeneity was noted for lower body force production (Tau2 = 1.546; I2 = 76.03%, p 2 = 1.386; I2 = 74.38%, p p ≤ 0.033), for BMD (− 0.48 to − 0.53, p p p g = − 0.49 [− 0.69 to – 0.28]), trochanter (Hedges g = − 0.53 [− 0.77 to – 0.29]), and lumbo-pelvic region (Hedges g = − 0.48 [− 0.73 to – 0.23]), but large decreases in lower limb force production (Hedges g = − 1.75 [− 2.50 to – 0.99]) and lower limb muscle size (Hedges g = − 1.98 [− 2.72 to – 1.23]). Conclusions Current exercise countermeasures result in small reductions in BMD during long-duration spaceflight. In contrast, such exercise protocols do not alleviate the reductions in muscle function or muscle size, which may be attributable to the low to moderate loads reported by crewmembers and the interference effect associated with concurrent training. It is recommended that higher-load resistance exercise and the use of high-intensity interval training should be investigated, to determine if such modifications to the reported training practices result in more effective countermeasures to the deleterious effect of long-duration spaceflight on the muscular system.

Background Cluster sets (CSs) are a popular resistance training (RT) strategy categorised by short rest periods implemented between single or groups of repetitions. However, evidence supporting the effectiveness of CSs on acute intra-session neuromuscular performance is still equivocal. Objective The objective of this investigation was to determine the efficacy of a single session of CSs to attenuate losses in force, velocity and power compared to traditional set (TS) training. Methods Screening consisted of a systematic search of EMBASE, Google Scholar, PubMed, Scopus and SPORTDiscus. Inclusion criteria were (1) measured one or more of mean/peak force, velocity or power; (2) implemented CSs in comparison to TSs; (3) an acute design, or part thereof; and (4) published in an English-language, peer-reviewed journal. Raw data (mean ± standard deviation) were extracted from included studies and converted into standardised mean differences (SMDs) and ± 95% confidence intervals (CIs). Results Twenty-five studies were used to calculate SMD ± 95% CI. Peak (SMD = 0.815, 95% CI 0.105–1.524, p = 0.024) and mean (SMD = 0.863, 95% CI 0.319–1.406, p = 0.002) velocity, peak (SMD = 0.356, 95% CI 0.057–0.655, p = 0.019) and mean (SMD = 0.692, 95% CI 0.395–0.990, p p = 0.031) favoured CS. Subgroup analyses demonstrated an overall effect for CS across loads (SMD = 0.702, 95% CI 0.548–0.856, p p p p Conclusion CSs are a useful strategy to attenuate the loss in velocity, power and peak force during RT and should be used to maintain neuromuscular performance, especially when kinetic outcomes are emphasised. However, it remains unclear if the benefits translate to improved performance across all RT exercises, between sexes and across the lifespan.

Low muscle mass in individuals with cancer has a profound impact on quality of life and independence and is associated with greater treatment toxicity and poorer prognosis. Exercise interventions are regularly being investigated as a means to ameliorate treatment-related adverse effects, and nutritional/supplementation strategies to augment adaptations to exercise are highly valuable. Creatine (Cr) is a naturally-occurring substance in the human body that plays a critical role in energy provision during muscle contraction. Given the beneficial effects of Cr supplementation on lean body mass, strength, and physical function in a variety of clinical populations, there is therapeutic potential in individuals with cancer at heightened risk for muscle loss. Here, we provide an overview of Cr physiology, summarize the evidence on the use of Cr supplementation in various aging/clinical populations, explore mechanisms of action, and provide perspectives on the potential therapeutic role of Cr in the exercise oncology setting.

This study aimed to investigate the effect of different set configurations on barbell trajectories during a series of power snatch sets. Ten strength-power athletes (height: 1.78 ± 0.09 m, body mass: 88.7 ± 14.3 kg, age: 28.9 ± 4.8 years) with at least 6 months of training experience performing the power snatch participated in this study. Each participant completed three experimental protocols as part of a randomized repeated measures design. The three protocols tested were a traditional, cluster, and ascending cluster set protocol where training loads were increased across the repetitions contained within each set. All protocols required each participant to perform the power snatch with three sets of five repetitions at an average load of 75% of one-repetition maximum. Three-dimensional barbell trajectories were recorded using a motion capture system during each set protocol. Participants maintained barbell trajectories within each set of both traditional and cluster protocols. This result indicates that higher intensities (>75% of one-repetition maximum) than those used in this study should be used when using cluster sets that are designed to maximize the benefits of cluster sets for maintaining barbell trajectories during a series of power snatch sets performed for five repetitions. Additionally, participants displayed an increased barbell loop at the first repetition during the ascending cluster protocol. Therefore, coaches should only use this programming strategy for highly trained athletes who have already developed proper weightlifting technique to avoid a suboptimal barbell trajectory during the power snatch training session.

The physical qualities that underpin successful junior judokas requires continuing investigation. We investigated the physical and physiological characteristics of junior national level judokas. We tested 25 (15 male, 10 female) Indian judokas for absolute and relative strength (back-squat and bench-press one-repetition maximum (1RM) as well as isometric handgrip), aerobic (RAMP test) and lower-body anaerobic power (Wingate 6-s sprint and countermovement jump), change-of-direction (5-0-5 test) and speed (30 m sprint). Athletes were grouped according to national-level competition placing (gold-medal winners (GM, n = 8), all medal winners (MW, n = 13), non-medallists (NM, n = 12), and NM plus silver and bronze, all others (AO, n = 17)). Stepwise discriminant function analysis determined characteristics likely to predict successful performance. Independent t-tests and effect size (Hedge&rsquo, s g) analyses were performed between groups. GM demonstrated greater lower-body absolute (20.0%, g = 0.87, p = 0.046) and relative 1RM strength (21.0%, g = 0.87, p = 0.047), and greater lower-body absolute (25.4%, g=1.32, p=0.004) and relative (27.3%, g = 1.27, p = 0.005) anaerobic power compared to AO. Furthermore, anaerobic power can correctly predict 76.5% and 62.5% of AO and GM athletes, respectively. No differences were observed between MW and NM groups. The results suggest the importance of lower-body strength and power for junior national-level judokas and provides information for professionals working with these athletes.

The increasing interest in weight loss has seen a concurrent rise in the supplemental use of thermogenics to aid weight loss efforts. To date, the effectiveness and safety of supplemental proprietary blend thermogenics, in conjunction with high-protein energy-restricted diets have not been thoroughly evaluated. The purpose of this study was to investigate the efficacy of a low-calorie, high-protein diet with and without the concomitant use of a thermogenic supplement on body weight and body composition in apparently healthy females. Subjects were divided into three groups, Bizzy Diet+FitMiss Burn (BURN, N = 12), Bizzy Diet+Placebo (PLA, N = 13), and Control (CON, N = 14), and underwent two testing sessions separated by approximately 3 weeks. Resting blood pressure (BP), resting heart rate (RHR), clinical safety markers, body weight (BW), and body composition were assessed during each testing session. Repeated measures analysis of variance (ANOVA) revealed a significant effect for time relative to BW, total body fat mass (FM), leg FM, and trunk FM. Post hoc analysis revealed that the BURN and PLA groups experienced significant decreases in both BW and total body FM compared to CON (p.05). There were no significant interactions for BP, RHR, or clinical safety markers over the course of the study. The Bizzy Diet, both with and without the addition of FitMiss Burn thermogenic, appears to be safe for short-term use and may lead to greater improvement in body composition and BW in an apparently healthy female population.

Purpose:To assess changes in body composition, lumbar-spine bone mineral density (BMD), and rowing performance in collegelevel rowers over a competition season.Methods:Eleven Division I college rowers (mean ± SD 21.4 ± 3.7 y) completed 6 testing sessions throughout the course of their competition season. Testing included measurements of fat mass, bone-free lean mass (BFLM), body fat (%BF), lumbar-spine BMD, and 2000-m time-trial performance. After preseason testing, rowers participated in a periodized training program, with the addition of resistance training to the traditional aerobic-training program.Results:Significant (P < .05) improvements in %BF, total mass, and BFLM were observed at midseason and postseason compared with preseason. Neither lumbar-spine BMD nor BMC significantly changed over the competitive season (P > .05). Finally, rowing performance (as measured by 2000-m time and average watts achieved) significantly improved at midseason and postseason compared with preseason.Conclusion:Our results highlight the efficacy of a seasonal concurrent training program serving to improve body composition and rowing performance, as measured by 2000-m times and average watts, among college-level rowers. Our findings offer practical applications for coaches and athletes looking to design a concurrent strength and aerobic training program to improve rowing performance across a season.

IntroductionCreatine supplementation has consistently been demonstrated to augment adaptations in body composition, muscle strength and physical function in a variety of apparently healthy older adults and clinical populations. The effects of creatine supplementation and resistance training in individuals with cancer have yet to be investigated. This study aims to examine the effects of creatine supplementation in conjunction with resistance training on body composition, muscle strength and physical function in prostate cancer patients undergoing androgen deprivation therapy.Methods and analysisThis is a randomised, double-blind, placebo-controlled trial designed to examine the effects of creatine supplementation in addition to resistance training in patients with prostate cancer receiving androgen deprivation therapy. Both supplement and placebo groups will receive a 12-week supervised exercise programme comprising resistance training undertaken three times per week. The primary endpoint (fat-free mass) and secondary endpoints (fat mass, per cent body fat, physical fitness, quality of life and blood biomarkers) will be assessed at baseline and immediately following the intervention.Ethics and disseminationThe Human Research Ethics Committee of Edith Cowan University approved this study (ID: 22243 FAIRMAN). If the results of this trial demonstrate that creatine supplementation can augment beneficial adaptations of body composition, physical function and/or psychosocial outcomes to resistance training, this study will provide effect sizes that will inform the design of subsequent definitive randomised controlled trials. The results of this study will be published in peer-reviewed journals and presented at various national and international conferences.Trial registration numberACTRN12619000099123

The purpose of this investigation was to determine body composition classification using field-based testing measurements in healthy elderly men and women. The use of isoperformance curves is presented as a method for this determination. Baseline values from 107 healthy Caucasian men and women, over the age of 65 years old, who participated in a separate longitudinal study, were used for this investigation. Field-based measurements of age, height, weight, body mass index (BMI), and handgrip strength were recorded on an individual basis. Relative skeletal muscle index (RSMI) and body fat percentage (FAT%) were determined by dual-energy X-ray absorptiometry (DXA) for each participant. Sarcopenia cut-off values for RSMI of 7.26 kg·m− 2 for men and 5.45 kg·m− 2 for women and elderly obesity cut-off values for FAT% of 27% for men and 38% for women were used. Individuals above the RSMI cut-off and below the FAT% cut-off were classified in the normal phenotype category, while individuals below the RSMI cut-off and above the FAT% cut-off were classified in the sarcopenic-obese phenotype category. Prediction equations for RSMI and FAT% from sex, BMI, and handgrip strength values were developed using multiple regression analysis. The prediction equations were validated using double cross-validation. The final regression equation developed to predict FAT% from sex, BMI, and handgrip strength resulted in a strong relationship (adjusted R2 = 0.741) to DXA values with a low standard error of the estimate (SEE = 3.994%). The final regression equation developed to predict RSMI from the field-based testing measures also resulted in a strong relationship (adjusted R2 = 0.841) to DXA values with a low standard error of the estimate (SEE = 0.544 kg·m− 2). Isoperformance curves were developed from the relationship between BMI and handgrip strength for men and women with the aforementioned clinical phenotype classification criteria. These visual representations were used to aid in the classification and evaluation of sarcopenia, obesity, and sarcopenic-obesity in elderly individuals. Future research should replicate the current findings with an increased sample size and the development of tailored interventions for each body composition category.

To compare single estimations of fat-free mass (FFM) and to track FFM using single-frequency bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA) compared with a four-compartment (4C) model in healthy elderly Americans. Thirty-four men and thirty-eight women (Caucasian, ⩾65 years) were included in the study. Subjects participated in either the control group or the exercise group. All testing and training took place during the 21-week investigation. Body composition assessments using nine BIA equations, DXA and a 4C model were performed during weeks 1, 12 and 24 of the study. Single estimations for DXA and BIA produced high r values (0.79–0.95) and low standard error of estimate values (1.62–3.3 kg), producing subjective ratings of ‘ideal’ for men and ‘excellent’ for women. Both DXA and two BIA equations revealed the same significance when comparing groups and times with the 4C model. Individual accuracy for tracking changes was similar among BIA equations and DXA compared with the 4C model, with a total agreement of 25% for BIA and 27% for DXA compared with the 4C model. The current data in combination with the reliability errors for both BIA and DXA FFM estimations suggest that individual results should be interpreted with caution if FFM changes are

Hyde, PN, Kendall, KL, Fairman, CM, Coker, NA, Yarbrough, ME, and Rossi, SJ. Utilization of B-mode ultrasound as a body fat estimate in collegiate football players. J Strength Cond Res 30(12): 3525-3530, 2016-The purpose of the present study was to validate a 7-site ultrasound imaging protocol to predict the percent body fat (%BF) in a division I football team. Body composition was estimated by ultrasound, 7-site skinfolds, and the 3-compartment-water (3C-W) model of Siri, using bioimpedance spectroscopy to estimate the total body water and air displacement plethysmography (using BODPOD) to determine the body density. Pearson's product-moment correlation analyses were run to determine correlations between ΣUltrasound and the criterion 3C-W, and between the ΣSkinfold and ΣUltrasound. Strong positive correlations were observed between ΣSkinfold and ΣUltrasound (r = 0.984; p < 0.001). Furthermore, a strong positive correlation was observed between ΣUltrasound and %BF from 3C-W (r = 0.878; p < 0.001). Based on the significant correlation analysis, a linear regression equation was developed to predict the %BF from ΣUltrasound, using %BF from the 3C-W model as the dependent variable: %BF = 6.194 + (0.096 × ΣUltrasound); standard error of the estimate (SEE) = 2.97%. Cross-validation analyses were performed using an independent sample of 29 players. The mean observed %BF from the 3C-W model and the mean predicted %BF were 18.32 ± 6.26% and 18.78 ± 6.22%, respectively. The constant error, SEE, and validity coefficient (r) were 0.87%, 2.64%, and 0.91%, respectively. The total error was 2.87%. The positive relationship between ultrasound measurements and the 3C-W model suggests that ultrasound imaging may be a practical alternative to predicting %BF in division I football players.

The objective of this study was to compare the chronic effects of different whey protein forms on body composition and performance when supplemented with resistance training.Resistance-trained men (N = 56, 21.4 ± 0.4 years, 79.5 ± 1.0 kg) participated in an 8-week resistance training regimen (2 upper-body sessions and 2 lower-body sessions per week) and received one of 4 double-blinded treatments: 30 g/serving carbohydrate placebo (PLA) or 30 g/serving protein from either (a) 80% whey protein concentrate (WPC), (b) high-lactoferrin-containing WPC (WPC-L), or (c) extensively hydrolyzed WPC (WPH). All subjects consumed 2 servings of treatment per day; specifically, once immediately before and after training and between meals on nontraining days. Blood collection, one repetition maximum (1RM) testing for bench press and hack squat, and body composition assessment using dual-energy x-ray absorptiometry (DXA) occurred prior to training and 48 hours following the last training session.Total body skeletal muscle mass increased in all groups (p0.0125). There were similar between-group increases in upper-body (4%-7%, analysis of covariance [ANCOVA] interaction p = 0.73) and lower-body (24%-35%, ANCOVA interaction p = 0.85) 1RM strength following the intervention. Remarkably, WPH reduced fat mass (-6%), which was significantly different from PLA (+4.4%, p0.0125). No time or between-group differences were present for serum markers of health, metabolism, or muscle damage, with the exception of blood urea nitrogen being significantly lower for WPH than WPC (p0.05) following the intervention.WPH may augment fat loss but did not provide any other advantages when used in combination with resistance training. More mechanistic research is needed to examine how WPH affects adipose tissue physiology.

P1 Impact of antioxidant-enriched nutrient bar supplementation on the serum antioxidant markers and physical fitness components of track and field athletes

Hemmings, TJ, Kendall, KL, and Dobson, JL. Identifying dosage effect of light-emitting diode therapy on muscular fatigue in quadriceps. J Strength Cond Res 31(2): 395-402, 2017-The purpose of this study was to compare the effects of various dosages of light-emitting diode therapy (LEDT) on muscle fatigue while performing a single-leg extension to exhaustion. A total of 34 recreationally resistance-trained athletes between the ages of 18 and 26 participated in 4 trials. Each trial included pre-exercise/postexercise blood lactate measurements and 2 sets of 3 maximal voluntary isometric contractions (MVICs), followed by LEDT on 6 points across the superficial quadriceps. Each randomized trial consisted of a placebo, 30, 60, or 120 seconds on each point on the quadriceps. Three minutes after LEDT, the participants performed an eccentric leg extension with 120% of MVIC until fatigue. There was significant increase in the number of repetitions performed between the placebo treatment and 60 seconds (p = 0.023), as well as placebo and 120 seconds (p = 0.004) of irradiation on each point. There were no significant differences in blood lactate levels between any of the 4 trials. In conclusion, LEDT had a positive effect on performance when irradiating 6 points on the superficial quadriceps for 60 and 120 seconds before an eccentric leg extension.

Breast Cancer survivors can experience a myriad of physical and psychological benefits as a result of regular exercise. This study aimed to build on previous research using lower impact exercise programs by using an antigravity (Alter-G®) treadmill to administer cardiovascular training. The purpose of this study was to determine the effectiveness a physical activity program, including an Alter-G® treadmill, for improving physiological and psychosocial measures in female breast cancer survivors. A 14-week intervention using an AB-AB study design was employed. Six female breast cancer survivors were recruited to participate in the study. Participants attended three 60-minute sessions per week, consisting of a combination of muscular strength/endurance, and cardiovascular endurance exercises. Consistent with current literature and guidelines, exercise interventions were individualized and tailored to suit individuals. Data was collected and analyzed in 2013. Visual inspection of results found improvements in cardiovascular endurance and measures of body composition. Quality of life was maintained and in some cases, improved. Finally, no adverse effects were reported from the participants, and adherence to the program for those who completed the study was 97%. The results of this study suggest that the use of a physical activity program in combination with an Alter-G® treadmill may provide practical and meaningful improvements in measures of cardiovascular endurance and body composition.

Background While it is known that dietary supplements containing a combination of thermogenic ingredients can increase resting metabolic rate (RMR), the magnitude can vary based on the active ingredient and/or combination of active ingredients. The purpose of this study was to examine the effects of a commercially available thermogenic fat loss supplement on RMR and hemodynamic variables in healthy, resistance trained males. Methods Ten resistance-trained male participants (29 ± 9 years; 178 ± 4 cm; 85.7 ± 11 kg, and BMI = 26.8 ± 3.7) volunteered to participate in this randomized, double-blind, placebo controlled cross-over study. Participants underwent two testing sessions separated by at least 24 h. On their first visit, participants arrived to the laboratory after an overnight fast and a 24-h avoidance of exercise, and underwent a baseline RMR, HR, and BP assessment. Next, each participant ingested a thermogenic fat loss supplement (TFLS) or a placebo (PLA) and repeated the RMR, HR, and BP assessments at 60, 120, and 180 min post-ingestion. During the second visit the alternative supplement was ingested and the assessments were repeated in the exact same manner. Data were analyzed via a 2-factor [2x4] within-subjects repeated measures analysis of variance (ANOVA). Post-hoc tests were analyzed via paired samples t-tests. The criterion for significance was set at p ≤ 0.05. Results A significant main effect for time relative to raw RMR data (p = 0.014) was observed. Post-hoc analysis revealed that the TFLS significantly increased RMR at 60-min, 120-min, and 180-min post ingestion (p 0.05). Specifically, RMR was increased by 7.8 % (from 1,906 to 2,057 kcal), 6.9 % (from 1,906 to 2,037 kcal), and 9.1 % (from 1,906 to 2,081 kcal) in the TFLS, while the PLA treatment increased RMR by 3.3 % (from 1,919 to 1,981 kcal), 3.1 % (from 1,919 to 1,978 kcal), and 2.1 % (from 1,919 to 1,959 kcal) above baseline at 60, 120, and 180-min post ingestion, respectively. Additionally, the TFLS significantly elevated RMR at the 3-h time point as compared to the PLA treatment (2,081 vs 1,959 kcal, p = 0.034). A main effect for groups was observed for systolic blood pressure, and a significant interaction and main effect for time were observed for diastolic blood pressure. It should be noted that although changes in diastolic blood pressure were significant, all values stayed within normal clinical ranges (

Both load cell and mechanical scale-based hydrostatic weighing (HW) systems are used for the measurement of underwater weight. However, there has been no direct comparison of the 2 methods. The purpose of the current investigation was to simultaneously compare a load cell and mechanical scale for use in HW. Twenty-seven men and women (mean ± SD, age: 22 ± 2 years) participated in the 2-day investigation. Each subject completed 2 HW assessments 24 hours apart. Single-day comparisons of all trials for both days revealed no significant difference between the mechanical scale and the load cell (mean difference0.016 kg, p0.05). True underwater weight values were not significantly different between methods for either days (mean difference0.014 kg, p0.05) and accounted for a mean difference in percent fat (%FAT) of0.108%. The 95% limits of agreement indicated a maximum difference between methods of 0.53% FAT. Both methods produced similar reliability SEM values (mechanical SEM0.72%FAT, load cell SEM0.75%FAT). In conclusion, there was no difference between mechanical scale and load cell measurements of underwater weights and the added precision of the load cell only marginally (0.16%FAT) improved day-to-day reliability. Either a mechanical scale or load cell can be used for HW with similar accuracy and reliability in young adults with a body mass index of 18.7-34.4 (5-25%FAT).

The aim of this study was to evaluate the combined effects of a 10-week exercise program with ingestion of caffeine and epigallocatechin-3-gallate (EGCG) on body composition, cardiovascular fitness, and strength in overweight and obese women. In a double-blind, placebo-controlled approach, overweight and obese women (n = 27) were randomly assigned to treatment groups with exercise (an active-supplementing group with exercise (EX-Act) and a placebo group with exercise (EX-PL)) or without exercise (an active-supplementing group without exercise (NEX-Act) and a placebo group without exercise (NEX-PL)). All participants consumed 1 drink per day for 10 weeks; EX-Act and EX-PL participated in a concurrent endurance and resistance training program. Changes in body composition were assessed using a 4-compartment model. Changes in muscle mass (MM) were evaluated using a DXA-derived appendicular lean–soft tissue equation. There was a significant time × treatment interaction for MM (p = 0.026) and total cholesterol (TC) (p = 0.047), and a significant time × training interaction for peak oxygen consumption (p = 0.046) and upper-body and lower-body strength (p < 0.05). Significant differences between the EX groups and NEX groups for percentage change in MM and peak oxygen consumption, and upper-body and lower-body strength, were revealed. Clinical markers for hepatic and renal function revealed no adverse effects. TC significantly decreased for the active-supplementing groups (EX-Act, NEX-Act). The current study suggests that implementing a caffeine–EGCG-containing drink prior to exercise may improve MM, fitness, and lipid profiles in overweight women.

Energy drink use has grown despite limited research to support efficacy or safety and amid concerns when combined with exercise. The purpose of this study was to assess the effects of 10 weeks of once-daily energy drink consumption or energy drink consumption with exercise on measures of body composition, cardiorespiratory fitness, strength, mood, and safety in previously sedentary males. Thirty-eight males were randomly assigned to energy drink + exercise (EX-A), energy drink (NEX-A), placebo + exercise (EX-B), or placebo (NEX-B). All participants consumed 1 drink per day for 10 weeks; EX-A and EX-B participated in 10 weeks of resistance and endurance exercise. Testing was performed before (PRE) and after (POST) the 10-week intervention. No significant (p0.05) changes were observed for body composition, fitness, or strength in NEX-A; however, significantly greater decreases in fat mass and percentage body fat and increases in VO2peak were observed in EX-A versus EX-B. Ventilatory threshold (VT), minute ventilation, VO2 at VT, and power output at VT improved significantly PRE to POST in EX-A but not in EX-B or nonexercising groups. Clinical markers for hepatic, renal, cardiovascular, and immune function, as determined by PRE and POST blood work revealed no adverse effects in response to the energy drink. Mood was not affected by energy drink use. Absent energy restriction or other dietary controls, chronic ingestion of a once-daily low-calorie energy drink appears ineffective at improving body composition, cardiorespiratory fitness, or strength in sedentary males. However, when combined with exercise, preworkout energy drink consumption may significantly improve some physiological adaptations to combined aerobic and resistance training.

The submaximal electromyographic fatigue threshold test (EMGFT) has been shown to be highly correlated to ventilatory threshold (VT) as determined from maximal graded exercise tests (GXTs). Recently, a prediction equation was developed using the EMGFT value to predict VT. The aim of this study, therefore, was to determine if this new equation could accurately track changes in VT after high-intensity interval training (HIIT). Eighteen recreationally trained men (mean ± SD; age 22.4 ± 3.2 years) performed a GXT to determine maximal oxygen consumption rate ([latin capital V with dot above]o2peak) and VT using breath-by-breath spirometry. Participants also completed a discontinuous incremental cycle ergometer test to determine their EMGFT value. A total of four 2-minute work bouts were completed to obtain 15-second averages of the electromyographic amplitude. The resulting slopes from each successive work bout were used to calculate EMGFT. The EMGFT value from each participant was used to estimate VT from the recently developed equation. All participants trained 3 days a week for 6 weeks. Training consisted of 5 sets of 2-minute work bouts with 1 minute of rest in between. Repeated-measures analysis of variance indicated no significant difference between actual and predicted VT values after 3 weeks of training. However, there was a significant difference between the actual and predicted VT values after 6 weeks of training. These findings suggest that the EMGFT may be useful when tracking changes in VT after 3 weeks of HIIT in recreationally trained individuals. However, the use of EMGFT to predict VT does not seem to be valid for tracking changes after 6 weeks of HIIT. At this time, it is not recommended that EMGFT be used to predict and track changes in VT.

The critical power test provides 2 measures, critical power (CP) and anaerobic working capacity (AWC). In theory, the CP measurement represents the maximal power output that can be maintained without fatigue, and AWC is an estimate of work capacity associated with muscle energy reserves. High-intensity interval training (HIIT) has been shown to be an effective training method for improving endurance performance, including VO2PEAK. In addition, creatine (Cr) supplementation has been reported to improve AWC without training; however, it has shown no effect on CP. The purpose of this study was to examine the effects of 4 weeks of HIIT with Cr supplementation on CP and AWC. Forty-two recreationally active men volunteered to participate in this study. Participants were randomly assigned to 1 of 3 groups: Cr (n = 16), 10 g Cr + 10 g dextrose; placebo (PL, n = 16), 20 g dextrose; control (CON, n = 10), no treatment. Before and after supplementation, each participant performed a maximal oxygen consumption test VO2PEAK on a cycle ergometer to establish peak power output (PPO). Participants then completed a CP test involving 3 exercise bouts with the workloads set as a percentage of their PPO to determine CP and AWC. After a 2-week familiarization period of training and supplementing, PPO, CP, and AWC were remeasured before an additional 4 weeks of HIIT and supplementation were completed. Training consisted of 5 sets of 2-minute exercise bouts with 1 minute rest in between performed on the cycle ergometer, with intensities based on PPO. A significant improvement in CP was observed in the Cr group (6.72% +/- 2.54%), whereas PL showed no significant change (3.87% +/- 2.30%), and CON significantly decreased (6.27% +/- 2.38%). Furthermore, no changes in AWC were observed in any of the groups after treatment. The current findings suggest that Cr supplementation may enhance the effects of intense interval endurance training on endurance performance changes.

Raw bioelectrical impedance analysis (BIA) data [resistance (R); reactance (Xc)] through bioelectrical impedance vector analysis (BIVA) and phase angle (PhA) have been used to evaluate cellular function and hydration status. The purpose of this investigation was to examine the effects of resistance training (RT) on classic and specific BIVA in elderly women. Twenty women (mean ± SD; age: 71.9 ± 6.9 years; BMI: 24.5 ± 3.0 kg m(-2)) completed a 6-month RT program. Whole-body, single-frequency BIA, body geometry, and leg strength (5RM) measures were completed at baseline (t0), 3 months (t3), and 6 months (t6). The mean impedance vector displacements were compared using Hotelling's T(2) test to evaluate changes in R and Xc relative to height (R/ht; Xc/ht) or body volume (Rsp; Xcsp) estimated from the arms, legs, and trunk. 5RM, PhA, and BIVA variables were compared using ANOVA. PhA improved at t6 (p < 0.01), while 5RM improved at t3 and t6 (p < 0.01). Using classic BIVA, 6 months (T(2) = 31.6; p < 0.01), but not 3 months of RT (T(2) = 4.5; p = 0.20), resulted in significant vector migration. Using specific BIVA, 6 months (T(2) = 24.4; p < 0.01), but not 3 months of RT (T(2) = 5.5; p = 0.10), also resulted in significant vector migration. 5RM was correlated to both PhA (r = 0.48-56) and Xcsp (r = 0.45-53) at all time points. Vector displacements were likely the result of improved cellular integrity (Xcsp) and cellular health (PhA).

This investigation aimed to compare hydrostatic weighing (HW) with near-infrared interactance (NIR) and skinfold measurements (SKF) in estimating body fat percentage (FAT%) in rowing athletes. FAT% was estimated in 20 elite male rowers (mean ± SD: age = 24·8 ± 2·2 years, height = 191·0 ± 6·8 cm, weight = 86·8 ± 11·3 kg, HW FAT% = 11·50 ± 3·16%) using HW with residual volume, 3-site SKF and NIR on the biceps brachii. Predicted FAT% values for NIR and SKF were validated against the criterion method of HW. Constant error was not significant for NIR (-0·06, P = 0·955) or SKF (-0·20, P = 0·813). Neither NIR (r = 0·045) nor SKF (r = 0·229) demonstrated significant validity coefficients when compared to HW. The standard error of the estimate values for NIR and SKF were both less than 3·5%, while total error was 4·34% and 3·60%, respectively. When compared to HW, SKF and NIR provide similar mean values when compared to HW, but the lack of apparent relationships between individual values and borderline unacceptable total error may limit their application in this population.

The effects of 12-weeks of HMB ingestion and resistance training (RT) on abdominal adiposity were examined in 48 men (66-78 yrs). All participants were randomly assigned to 1 of 4 groups: no-training placebo (NT-PL), HMB only (NT-HMB), RT with PL (RT-PL), or HMB with RT (RT-HMB). DXA was used to estimate abdominal fat mass (AFM) by placing the region of interest over the L1-L4 region of the spine. Outcomes were assessed by ANCOVA, with Bonferroni-corrected pairwise comparisons. Baseline AFM values were used as the covariate. The ANCOVA indicated a significant difference (p = 0.013) between group means for the adjusted posttest AFM values (mean (kg) ± SE: NT-PL = 2.59 ± 0.06; NT-HMB = 2.59 ± 0.61; RT-PL = 2.59 ± 0.62; RT-HMB = 2.34 ± 0.61). The pairwise comparisons indicated that AFM following the intervention period in the RT-HMB group was significantly less than NT-PL (p = 0.013), NT-HMB (p = 0.011), and RT-PL (p = 0.010). These data suggested that HMB in combination with 12 weeks of RT decreased AFM in elderly men.

Fifty-six men (21.4±0.4 yrs) were randomly assigned to one of four double-blinded treatments: 60 g/d maltodextrin (PLA) or 60 g/d whey protein from either a) 80% whey protein concentrate (WPC80), b) high lactoferrin WPC80 (WPC80+), or c) hydrolyzed WPC80 (WPH). All subjects participated in an 8-week resistance training program. Two-way repeated measures ANCOVAs were used for statistical analyses. No between- or within-group (p>0.05 and p>0.0125, respectively) changes were observed for 12-hour fasted blood lipids, glucose, WBC, CK or other clinical chemistry markers of safety; however, all groups reduced (p

The purpose of this study was to examine the validity and reliability of estimated parameters of the work-time relationship during cross-country ski ergometry using the traditional multi-trial critical power (CP) test and a 3 min 'all-out' test (3MT). Fourteen recreationally active male participants (mean ± SD; age: 22.14 ± 2.85 yrs; height: 177.09 ± 6.57 cm; weight: 85.68 ± 13.56 kg) completed three testing visits. All testing was conducted using an upper-body ergometer (SkiErg, Concept2, Inc., Morrisville, VT). A graded exercise test was used to determined maximal oxygen uptake (VO2peak). Two separate 3MT sessions were used to determine oxygen uptake (VO23MT), end-test power (EP), work above end-test power (WEP) and end stroke rate (ESR). Additionally, three time trials completed in a single day at simulated distances of 300 m, 650 m and 1000 m were used to estimate CP, W' and critical stroke rate (CSR). VO2peak (3.65 ± 0.50 l · min(-1)) and VO23MT (3.59 ± 0.4 l · min(-1)) were not significantly different (p = 0.162). Intraclass correlation coefficients for EP, WEP and ESR were 0.809, 0.611 and 0.783, respectively. EP (148 ± 33 W) and CP (157 ± 49 W), were not significantly different between the testing methodologies (p = 0.290) and were highly correlated (r = 0.780). WEP (8.4 ± 3.0 kJ) and W' (8.3 ± 3.0 kJ) were similar (p = 0.947) but not related (r = 0.119), while ESR (45 ± 7 spm) and CSR (47 ± 7 spm) values were not significantly different (p = 0.238) and moderately correlated (r = 0.498). The 3MT using ski ergometry was shown to produce concurrently valid results with the traditional multi-trial CP test for CP and CSR, but not W', and elicited similar maximal oxygen uptake values when compared to a graded exercise test.

The purpose of this study was to determine the safety and efficacy of consuming a preworkout supplement (SUP) containing caffeine, creatine, β-alanine, amino acids, and B vitamins for 28 days. We hypothesized that little to no changes in kidney and liver clinical blood markers or resting heart rate and blood pressure (BP) would be observed. In addition, we hypothesized that body composition and performance would improve in recreationally active males after 28 days of supplementation. In a double-blind, placebo-controlled study, participants were randomly assigned to ingest one scoop of either the SUP or placebo every day for 28 days, either 20 minutes before exercise or ad libitum on nonexercise days. Resting heart rate and BP, body composition, and fasting blood samples were collected before and after supplementation. Aerobic capacity as well as muscular strength and endurance were also measured. Significant (P < .05) main effects for time were observed for resting heart rate (presupplementation, 67.59 ± 7.90 beats per minute; postsupplementation, 66.18 ± 7.63 beats per minute), systolic BP (presupplementation, 122.41 ± 11.25 mm Hg; postsupplementation, 118.35 ± 11.58 mm Hg), blood urea nitrogen (presupplementation, 13.12 ± 2.55 mg/dL; postsupplementation, 15.24 ± 4.47 mg/dL), aspartate aminotransferase (presupplementation, 34.29 ± 16.48 IU/L; postsupplementation, 24.76 ± 4.71 IU/L), and alanine aminotransferase (presupplementation, 32.76 ± 19.72 IU/L; postsupplementation, 24.88 ± 9.68 IU/L). Significant main effects for time were observed for body fat percentage (presupplementation, 15.55% ± 5.79%; postsupplementation, 14.21% ± 5.38%; P = .004) and fat-free mass (presupplementation, 70.80 ± 9.21 kg; postsupplementation, 71.98 ± 9.27 kg; P = .006). A significant decrease in maximal oxygen consumption (presupplementation, 47.28 ± 2.69 mL/kg per minute; postsupplementation, 45.60 ± 2.81 mL/kg per minute) and a significant increase in percentage of oxygen consumption per unit time at which ventilatory threshold occurred (presupplementation, 64.38% ± 6.63%; postsupplementation, 70.63% ± 6.39%) and leg press one-repetition maximum (presupplementation, 218.75 ± 38.43 kg; postsupplementation, 228.75 ± 44.79 kg) were observed in the SUP only. No adverse effects were noted for renal and hepatic clinical blood markers, resting heart rate, or BP. Supplements containing similar ingredients and doses should be safe for ingestion periods lasting up to 28 days in healthy, recreationally trained, college-aged men.

BackgroundEvidence suggests CaHMB may impact muscle mass and/or strength in older adults, yet no long-term studies have compared its effectiveness in sedentary and resistance training conditions. The purpose of this study was to evaluate the effects of 24weeks of CaHMB supplementation and resistance training (3dwk−1) or CaHMB supplementation only in ≥65yr old adults.MethodsThis double-blinded, placebo-controlled, trial occurred in two phases under ad libitum conditions. Phase I consisted of two non-exercise groups: (a) placebo and (b) 3g CaHMB consumed twice daily. Phase II consisted of two resistance exercise groups: (a) placebo and resistance exercise and (b) 3g CaHMB consumed twice daily and resistance exercise (RE). Strength and functionality were assessed in both phases with isokinetic leg extension and flexion at 60°·s−1 and 180°·s−1 (LE60, LF60, LE180, LF180), hand grip strength (HG) and get-up-and-go (GUG). Dual X-Ray Absorptiometry (DXA) was used to measure arm, leg, and total body lean mass (LM) as well as total fat mass (FM). Muscle Quality was measured for arm (MQHG=HG/arm LM) and Leg (MQ60=LE60/leg LM) (MQ180=LE180/leg LM).ResultsAt 24weeks of Phase I, change in LE60 (+8.8%) and MQ180 (+20.8%) for CaHMB was significantly (p

The use of β-alanine in sport is widespread. However, the effects across all sport activities are inconclusive. The purpose of this study was to evaluate the effects of β-alanine supplementation on high-intensity running performance and critical velocity (CV) and anaerobic running capacity (ARC). Fifty recreationally trained men were randomly assigned, in a double-blind fashion, to a β-alanine group (BA, 2 × 800 mg tablets, 3 times daily; CarnoSyn; n = 26) or placebo group (PL, 2 × 800 mg maltodextrin tablets, 3 times daily; n = 24). A graded exercise test (GXT) was performed to establish peak velocity (PV). Three high-speed runs to exhaustion were performed at 110, 100, and 90% of PV, with 15 minutes of rest between bouts. The distances achieved were plotted over the time to exhaustion (TTE). Linear regression was used to determine the slope (CV) and y-intercept (ARC) of these relationships to assess aerobic and anaerobic performances, respectively. There were no significant treatment effects (p > 0.05) on CV or ARC for either men or women. Additionally, no TTE effects were evident for bouts at 90-110%PV lasting 1.95-5.06 minutes. There seems to be no ergogenic effect of β-alanine supplementation on CV, ARC, or high-intensity running lasting approximately 2-5 minutes in either men or women in the current study.

The purpose of this study was to characterize the adaptations imposed by 4 weeks of precompetition judo training in youth athletes. It was hypothesized that anthropometric and sport-specific performance would improve during the preparation for a junior national championship event. Twenty youth athletes (mean ± SD; chronological age: 13.1 ± 3.2 years; training age: 5.3 ± 3.5 years; judo experience: 7.8 ± 2.5 hours per week) completed pretesting and posttesting procedures. Child (12 years old; n = 8) and adolescent (13 years old; n = 12) groups were evaluated to determine the anthropometric and sport-specific performance changes caused by 4 weeks of judo training conducted in preparation for the junior national championships. The child group showed an increase in flexibility (11.5%), and the adolescent group showed a decrease in skinfold thickness (-12.2%); increased jumping power (26.7%), force (7.7%), and velocity (19.0%); and improved judo-specific ability (-5.9%), as measured by the Special Judo Fitness Test (SJFT) index. Additionally, the SJFT index for all the study participants was shown to be inversely correlated to handgrip strength (r = -0.681), rope pull performance (r = -0.545), and jump height (r = -0.503). These results support the use of preparatory judo training in the improvement of anthropometric and sport-specific measures in adolescent athletes. Furthermore, the outcomes from this study provide direction for coaches and trainers in their efforts to impact physical performance and judo skills in children and adolescents through precompetition training.

The purpose of this study was to evaluate the use of critical velocity (CV) and isoperformance curves as an alternative to the Army Physical Fitness Test (APFT) two-mile running test. Seventy-eight men and women (mean +/- SE; age: 22.1 +/- 0.34 years; VO2(MAX): 46.1 +/- 0.82 mL/kg/min) volunteered to participate in this study. A VO2(MAX) test and four treadmill running bouts to exhaustion at varying intensities were completed. The relationship between total distance and time-to-exhaustion was tracked for each exhaustive run to determine CV and anaerobic running capacity. A VO2(MAX) prediction equation (Coefficient of determination: 0.805; Standard error of the estimate: 3.2377 mL/kg/min) was developed using these variables. Isoperformance curves were constructed for men and women to correspond with two-mile run times from APFT standards. Individual CV and anaerobic running capacity values were plotted and compared to isoperformance curves for APFT 2-mile run scores. Fifty-four individuals were determined to receive passing scores from this assessment. Physiological profiles identified from this procedure can be used to assess specific aerobic or anaerobic training needs. With the use of time-to-exhaustion as opposed to a time-trial format used in the two-mile run test, pacing strategies may be limited. The combination of variables from the CV test and isoperformance curves provides an alternative to standardized time-trial testing.

The objective of this study was to examine the relationship between the critical velocity (CV) test and maximal oxygen consumption (VO2max) and develop a regression equation to predict VO2max based on the CV test in female collegiate rowers. Thirty-five female (mean ± SD; age, 19.38 ± 1.3 years; height, 170.27 ± 6.07 cm; body mass, 69.58 ± 0.3 1 kg) collegiate rowers performed 2 incremental VO2max tests to volitional exhaustion on a Concept II Model D rowing ergometer to determine VO2max. After a 72-hour rest period, each rower completed 4 time trials at varying distances for the determination of CV and anaerobic rowing capacity (ARC). A positive correlation was observed between CV and absolute VO2max (r = 0.775, p0.001) and ARC and absolute VO2max (r = 0.414, p = 0.040). Based on the significant correlation analysis, a linear regression equation was developed to predict the absolute VO2max from CV and ARC (absolute VO2max = 1.579[CV] + 0.008[ARC] - 3.838; standard error of the estimate [SEE] = 0.192 L·min(-1)). Cross validation analyses were performed using an independent sample of 10 rowers. There was no significant difference between the mean predicted VO2max (3.02 L·min(-1)) and the observed VO2max (3.10 L·min(-1)). The constant error, SEE and validity coefficient (r) were 0.076 L·min(-1), 0.144 L·min(-1), and 0.72, respectively. The total error value was 0.155 L·min(-1). The positive relationship between CV, ARC, and VO2max suggests that the CV test may be a practical alternative to measuring the maximal oxygen uptake in the absence of a metabolic cart. Additional studies are needed to validate the regression equation using a larger sample size and different populations (junior- and senior-level female rowers) and to determine the accuracy of the equation in tracking changes after a training intervention.

This study evaluated the effects of creatine (Cr) loading and sex differences on aerobic running performance. 27 men (mean±SD; age: 22.2±3.1 years, ht: 179.5±8.7 cm, wt: 78.0±9.8 kg) and 28 women (age: 21.2±2.1 years, ht: 166.0±5.8 cm, wt: 63.4±8.9 kg) were randomly assigned to either creatine (Cr, di-creatine citrate; n=27) or a placebo (PL; n=28) group, ingesting 1 packet 4 times daily (total of 20 g/day) for 5 days. Aerobic power (maximal oxygen consumption: VO2max) was assessed before and after supplementation using open circuit spirometry (Parvo-Medics) during graded exercise tests on a treadmill. 4 high-speed runs to exhaustion were conducted at 110, 105, 100, and 90% of peak velocity to determine critical velocity (CV). Distances achieved were plotted over times-to-exhaustion and linear regression was used to determine the slopes (critical velocity, CV) assessing aerobic performance. The results indicated that Cr loading did not positively or negatively influence VO2max, CV, time to exhaustion or body mass (p>0.05). These results suggest Cr supplementation may be used in aerobic running activities without detriments to performance.

The purpose of this study was to evaluate the effects of β-alanine supplementation on markers of oxidative stress. Twenty-four women (age: 21.7 ± 2.1 years; VO2max: 2.6 ± 0.3 l min−1) were randomly assigned, in a double-blind fashion, to a β-alanine (BA, 2 × 800 mg tablets, 3× daily; CarnoSyn®; n = 13) or placebo (PL, 2 × 800 mg maltodextrin tablets, 3× daily; n = 11) group. A graded oxygen consumption test (VO2max) was performed to evaluate VO2max, time to exhaustion, ventilatory threshold and establish peak velocity (PV). A 40-min treadmill run was used to induce oxidative stress. Total antioxidant capacity, superoxide dismutase, 8-isoprostane (8ISO) and reduced glutathione were measured. Heart rate and ratings of perceived exertion were recorded during the 40 min run. Separate three- [4 × 2 × 2; acute (base vs. IP vs. 2 vs. 4 h) × chronic (pre- vs. post-) × treatment (BA vs. PL)] and two- [2 × 2; time (pre-supplement vs. post-supplement) × treatment (BA vs. PL)] way ANOVAs were used for analyses. There was a significant increase in VO2max (p = 0.009), independent of treatment, with no significant changes in TTE (p = 0.074) or VT (p = 0.344). Ratings of perceived exertion values were significantly improved from pre- to post-supplementation for the BA group only at 40 min (p = 0.02). The ANOVA model demonstrated no significant treatment effects on oxidative stress. The chronic effects of BA supplementation demonstrated little antioxidant potential, in women, and little influence on aerobic performance assessments.

The purpose of this study was to examine the reliability of the intermittent critical velocity (ICV) test and assess critical rest interval (CRI) during repeated-sprint exercise. The ICV test is used to examine the linear relationship between total distance and time-to-exhaustion during interval exercise, yielding a repeatable, moderate-intensity parameter (ICV), a high-intensity exhaustive parameter (W'), and CRI. CRI is the theoretical rest period needed to complete a series of repeated bouts of exercise without fatigue. Twenty-four healthy college-aged men (mean ± SD; age 22.7 ± 2.9 years; weight 85.8 ± 15.3 kg; VO(2max) 50.7 ± 8.8 ml/kg/min) and women (mean ± SD; age 21.4 ± 2.3 years; weight 58.9 ± 5.2 kg; VO(2max) 46.4 ± 4.4 ml/kg/min) participants completed two ICV tests (T1 and T2), using 10 s repeated sprints to exhaustion during separate sessions of treadmill running. Linear regression was used to determine ICV and W', while CRI was calculated using the relationship between the number of intervals completed and a variant of ICV. Intraclass correlation coefficients (ICCs) for ICV, W', and CRI were 0.89 (T1 4.42 ± 0.55 m/s; T2 4.34 ± 0.67 m/s), 0.80 (T1 125.6 ± 62.7 m; T2 144.6 ± 65.4 m), and 0.59 (T1 23.9 ± 2.0 s; T2 24.5 ± 2.6 s), respectively. These moderate to high ICC values indicate reliable measurements between ICV trials. Additionally, the evaluation of CRI demonstrated the attainment of a steady-state heart rate (94% of maximum) during a separate session of repeated supramaximal treadmill sprints. The ICV test during treadmill running provides reliable ICV and W' measures, as well as an estimated recovery time via CRI for men and women.